1. P-Glycoprotein 1 Affects Chemoactivities of Resveratrol against Human Colorectal Cancer Cells
   Virginie Aires et al, 2019, Nutrients CrossRef
2. Resveratrol Effects on Molecular Pathways and MicroRNAs in Gastrointestinal Cancers
   Amirhossein Davoodvandi et al, 2023, Current Medicinal Chemistry CrossRef
3. Piceatannol, a Structural Analog of Resveratrol, Is an Apoptosis Inducer and a Multidrug Resistance Modulator in HL-60 Human Acute Myeloid Leukemia Cells
   Kamila Siedlecka-Kroplewska et al, 2021, International Journal of Molecular Sciences CrossRef
4. Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer
   Li-Yan Wang et al, 2020, World Journal of Clinical Cases CrossRef
5. Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers
   Katarzyna Ratajczak et al, 2021, Molecules CrossRef
6. Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review
   Si-Xia Wu et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
7. Estrategias para evaluación de extractos de polifenoles en modelos in vitro de cáncer de vías digestivas
   Atilio Junior Ferrebuz-Cardozo et al, 2022, Revista Investigación en Salud Universidad de Boyacá CrossRef
8. Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids
   Ondrej Vesely et al, 2021, Nutrients CrossRef
9. Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer
   Kai Zhang et al, 2020, PeerJ CrossRef
10. Network pharmacology analyzes resveratrol targets for gastric cancer and modifies its structure
    Xinyang Cao et al, 2023, 2023 2nd International Conference on Health Big Data and Intelligent Healthcare (ICHIH) CrossRef
11. Effect of Resveratrol Treatment on Human Pancreatic Cancer Cells through Alterations of Bcl-2 Family Members
    Katarzyna Ratajczak et al, 2021, Molecules CrossRef
12. Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer
    Qing-Hua Liu et al, 2020, Investigational New Drugs CrossRef